Skip to Main Content

Paper Details

Development and validation of a REcurrent Liver cAncer Prediction ScorE (RELAPSE) following liver transplantation in patients with hepatocellular carcinoma: Analysis of the US Multicenter HCC Transplant Consortium.
Liver Transpl
7
2023
HCC, Hepatocellular Cancer, Liver cAncer, RELAPSE, alpha-fetoprotein, hepatocellular carcinoma, lymphocyte, neutrophil, patient, patients, tumor
Author NameAffiliation
Daniela MarkovicUniversity of California los angeles
Thomas M FishbeinMedstar Georgetown Transplant Institute, Georgetown University
Vatche G AgopianDavid Geffen School of Medicine at university of california los angeles, Dumont-university of california los angeles (University of California, Los Angeles) Transplant and Liver Cancer Centers
  • 1 - 3

Datasets

Release 1.2